Cyclosporine Treatment in Severe Gestational Pemphigoid
Author(s) -
Laura Huilaja,
Kaarin Mäkikallio,
Katariina Hannula-Jouppi,
Liisa Väkevä,
Johanna HöökNikanne,
Kaisa Tasanen
Publication year - 2014
Publication title -
acta dermato venereologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.982
H-Index - 83
eISSN - 1651-2057
pISSN - 0001-5555
DOI - 10.2340/00015555-2032
Subject(s) - medicine , bullous pemphigoid , itching , dermatology , pemphigoid , pregnancy , autoantibody , gestation , immunology , antibody , genetics , biology
Gestational pemphigoid, a rare autoimmune skin disease typically occurring during pregnancy, is caused by autoantibodies against collagen XVII. Clinically it is characterised by severe itching followed by erythematous and bullous lesions of the skin. Topical or oral glucocorticoids usually relieve symptoms, but in more severe cases systemic immunosuppressive treatments are needed. Data on immunosuppressive medication controlling gestational pemphigoid are sparse. We report 3 intractable cases of gestational pemphigoid treated with cyclosporine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom